Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Findings from University of New South Wales provide new insights into cancer vaccines
June 30th, 2009
New investigation results, 'Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden,' are detailed in a study published in Journal of Viral Hepatitis. According to recent research published in the Journal of Viral Hepatitis, "Worldwide, 350 million people are chronically infected with hepatitis B virus (HBV) who are at greater risk of hepatocellular carcinoma (HCC) compared with uninfected people. The relative risks of HCC among people infected with HBV ranges from 5 to 49 in case-control studies and from 7 to 98 in cohort studies." "More than 50% of HCC cases worldwide and 70-80% of HCC cases in highly HBV endemic...
Source: Cancer Weekly (2009-06-30)
|
